Who and when to vaccinate against influenza

Adeloye, 2015, Global and regional estimates of COPD prevalence: Systematic review and meta-analysis, J Glob Health, 5, 10.7189/jogh.05.020415 Albrecht, 2014, Lack of persistence of influenza vaccine antibody titers in patients with heart failure, J Card Fail, 20, 105, 10.1016/j.cardfail.2013.12.008 Allard, 2010, Diabetes and the severity of pandemic influenza A (H1N1) infection, Diabetes Care, 33, 1491, 10.2337/dc09-2215 American Heart Association, 2015 Andrew, 2017, The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people, J Infect Dis, 216, 405, 10.1093/infdis/jix282 Andrew, 2019, Examining the knowledge, attitudes and experiences of Canadian seniors towards influenza (the EXACT survey), BMC Geriatr, 19, 178, 10.1186/s12877-019-1180-5 ANZIC Influenza Investigators, 2009, Critical care services and 2009 H1N1 influenza in Australia and New Zealand, N Engl J Med, 361, 1925, 10.1056/NEJMoa0908481 Asavapiriyanont, 2018, Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015, BMC Pregnancy Childbirth, 18, 110, 10.1186/s12884-018-1712-6 Asrani, 2019, Burden of liver diseases in the world, J Hepatol, 70, 151, 10.1016/j.jhep.2018.09.014 Australian Technical Advisory Group on Immunisation (ATAGI), 2018 Bekkat-Berkani, 2017, Seasonal influenza vaccination in patients with COPD: a systematic literature review, BMC Pulm Med, 17, 79, 10.1186/s12890-017-0420-8 Belongia, 2017, Repeated annual influenza vaccination and vaccine effectiveness: review of evidence, Expert Rev Vaccines, 16, 1, 10.1080/14760584.2017.1334554 Belshe, 2007, Live attenuated versus inactivated influenza vaccine in infants and young children, N Engl J Med, 356, 685, 10.1056/NEJMoa065368 Biswas, 2019, Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines, Int Rev Immunol, 1 Bitterman, 2018, Influenza vaccines in immunosuppressed adults with cancer, Cochrane Database Syst Rev, 2 Blanchette, 2019, Influenza vaccine effectiveness among patients with cancer: a population-based study using health administrative and laboratory testing data from Ontario, Canada, J Clin Oncol, 37, 2795, 10.1200/JCO.19.00354 Blanton, 2012, Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza, Pediatrics, 130, 390, 10.1542/peds.2011-3343 Boddington, 2019, Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015-2016 influenza season — a test-negative case-control study, Epidemiol Infect, 147, e201, 10.1017/S0950268819000876 Booy, 2012, Treating and preventing influenza in aged care facilities: a cluster randomised controlled trial, PLoS One, 7, 10.1371/journal.pone.0046509 Bosaeed, 2018, Seasonal influenza vaccine in immunocompromised persons, Hum Vaccin Immunother, 14, 1311, 10.1080/21645515.2018.1445446 Callahan, 2014, Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults, J Infect Dis, 210, 1270, 10.1093/infdis/jiu245 Casado, 2018, Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study, CMAJ, 190, E3, 10.1503/cmaj.170910 Cates, 2013, Vaccines for preventing influenza in people with asthma, Cochrane Database Syst Rev Chaves, 2014, The burden of influenza hospitalizations in infants from 2003 to 2012, United States, Pediatr Infect Dis J, 33, 912, 10.1097/INF.0000000000000321 Clar, 2015, Influenza vaccines for preventing cardiovascular disease, Cochrane Database Syst Rev Claeys, 2018, Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons, Lancet Child Adolesc Health, 2, 338, 10.1016/S2352-4642(18)30062-2 Committee for Proprietary Medicinal Products (CPMP), 1997 Cooksley, 2005, Epidemiology and outcomes of serious influenza-related infections in the cancer population, Cancer, 104, 618, 10.1002/cncr.21203 Cox, 2006, Hospitalizations with respiratory illness among pregnant women during influenza season, Obstet Gynecol, 107, 1315, 10.1097/01.AOG.0000218702.92005.bb Dabrera, 2014, Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14, Euro Surveill, 19, 20959, 10.2807/1560-7917.ES2014.19.45.20959 Daley, 2018, The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a vaccine safety Datalink study, Pharmacoepidemiol Drug Saf, 27, 59, 10.1002/pds.4349 De Keyser, 1998, Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis, J Neurol Sci, 159, 51, 10.1016/S0022-510X(98)00139-7 Demicheli, 2018, Vaccines for preventing influenza in the elderly, Cochrane Database Syst Rev, 2 Dignani, 2014, Pandemic 2009 influenza A(H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study, F1000Research, 3, 221, 10.12688/f1000research.5251.1 Doherty, 2016, Vaccination of special populations: protecting the vulnerable, Vaccine, 34, 6681, 10.1016/j.vaccine.2016.11.015 Dos Santos, 2018, Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: a systematic review, Hum Vaccin Immunother, 14, 1853, 10.1080/21645515.2018.1446719 Durando, 2011, Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine, Hum Vaccin, 7 Suppl, 29, 10.4161/hv.7.0.14560 Earle, 2003, Influenza vaccination in elderly patients with advanced colorectal cancer, J Clin Oncol, 21, 1161, 10.1200/JCO.2003.06.008 Eliakim-Raz, 2013, Influenza vaccines in immunosuppressed adults with cancer, Cochrane Database Syst Rev Englund, 1993, Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants, J Infect Dis, 168, 647, 10.1093/infdis/168.3.647 Esposito, 2016, Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children, Vaccine, 34, 56, 10.1016/j.vaccine.2015.11.019 Fang, 2016, Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: a population-based cohort study, Acta Cardiol Sin, 32, 290 Ferdinands, 2019, Waning of influenza vaccine protection: exploring the trade-offs of changes in vaccination timing among older adults, Clin Infect Dis Fisher-Hoch, 2013, Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases, Trop Med Int Health, 18, 1510, 10.1111/tmi.12206 Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1 Gaeta, 2002, Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis, Vaccine, 20, B33, 10.1016/S0264-410X(02)00510-8 Gaeta, 2009, Influenza vaccination in patients with cirrhosis and in liver transplant recipients, Vaccine, 27, 3373, 10.1016/j.vaccine.2009.01.077 Gaillat, 2009, Morbidity and mortality associated with influenza exposure in long-term care facilities for dependent elderly people, Eur J Clin Microbiol Infect Dis, 28, 1077, 10.1007/s10096-009-0751-3 GBD 2013 Mortality and Causes of Death Collaborators, 2015, Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 385, 117, 10.1016/S0140-6736(14)61682-2 GBD 2015 Neurological Disorders Collaborator Group, 2017, Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet Neurol, 16, 877, 10.1016/S1474-4422(17)30299-5 Global Initiative for Chronic Obstructive Lung Disease, 2019 Global Initiative for Asthma, 2018 Govaert, 1993, Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial, BMJ, 307, 988, 10.1136/bmj.307.6910.988 Gozalo, 2012, Effect of influenza on functional decline, J Am Geriatr Soc, 60, 1260, 10.1111/j.1532-5415.2012.04048.x Grohskopf, 2014, Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP)—United States, 2014-15 influenza season, MMWR Morb Mortal Wkly Rep, 63, 691 Grohskopf, 2015, Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2015-16 influenza season, MMWR Morb Mortal Wkly Rep, 64, 818, 10.15585/mmwr.mm6430a3 Grohskopf, 2018, Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2018-19 influenza season, MMWR Recomm Rep, 67, 1, 10.15585/mmwr.rr6703a1 Haberg, 2013, Risk of fetal death after pandemic influenza virus infection or vaccination, N Engl J Med, 368, 333, 10.1056/NEJMoa1207210 Hakim, 2016, Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection, Vaccine, 34, 3141, 10.1016/j.vaccine.2016.04.053 Hannoun, 2004, Immunogenicity and protective efficacy of influenza vaccination, Virus Res, 103, 133, 10.1016/j.virusres.2004.02.025 Hambidge, 2006, Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old, JAMA, 296, 1990, 10.1001/jama.296.16.1990 He, 2011, Plasmablast-derived polyclonal antibody response after influenza vaccination, J Immunol Methods, 365, 67, 10.1016/j.jim.2010.12.008 Henry, 2018, From original antigenic sin to the universal influenza virus vaccine, Trends Immunol, 39, 70, 10.1016/j.it.2017.08.003 Howard, 2013, Influenza vaccine for cardiovascular risk reduction, Hosp Pharm, 48, 813, 10.1310/hpj4810-813 Irving, 2000, Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study, BJOG, 107, 1282, 10.1111/j.1471-0528.2000.tb11621.x Ishigami, 2019, Clinical epidemiology of infectious disease among patients with chronic kidney disease, Clin Exp Nephrol, 23, 437, 10.1007/s10157-018-1641-8 Iuliano, 2018, Estimates of global seasonal influenza-associated respiratory mortality: a modelling study, Lancet, 391, 1285, 10.1016/S0140-6736(17)33293-2 Jhaveri, 2018, Live attenuated influenza vaccine: is past performance a guarantee of future results?, Clin Ther, 40, 1246, 10.1016/j.clinthera.2018.07.003 Jefferson, 2018, Vaccines for preventing influenza in healthy children, Cochrane Database Syst Rev, 2 Jha, 2013, Chronic kidney disease: global dimension and perspectives, Lancet, 382, 260, 10.1016/S0140-6736(13)60687-X Johnstone, 2012, Influenza vaccination and major adverse vascular events in high-risk patients, Circulation, 126, 278, 10.1161/CIRCULATIONAHA.111.071100 Jones, 2014, Antenatal immunization, Hum Vaccin Immunother, 10, 2118, 10.4161/hv.29610 Jordan, 2006, Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence, Vaccine, 24, 1047, 10.1016/j.vaccine.2005.09.017 Joshi, 2009, Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study, Vaccine, 27, 4457, 10.1016/j.vaccine.2009.05.038 Khurana, 2019, Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans, Nat Commun, 10, 3338, 10.1038/s41467-019-11296-5 Kopsaftis, 2018, Influenza vaccine for chronic obstructive pulmonary disease (COPD), Cochrane Database Syst Rev, 6 Kostikas, 2016, Prediction and prevention of exacerbations and mortality in patients with COPD, Expert Rev Respir Med, 10, 739, 10.1080/17476348.2016.1185371 Kotecha, 2016, Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer, Cancer Med, 5, 285, 10.1002/cam4.596 Kourtis, 2014, Pregnancy and infection, N Engl J Med, 370, 2211, 10.1056/NEJMra1213566 Krammer, 2018, Influenza, Nat Rev Dis Primers, 4, 3, 10.1038/s41572-018-0002-y Kwong, 2018, Acute myocardial infarction after laboratory-confirmed influenza infection, N Engl J Med, 378, 345, 10.1056/NEJMoa1702090 Lapi, 2019, Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly, Expert Rev Vaccines, 18, 663, 10.1080/14760584.2019.1622418 Luyckx, 2018, The global burden of kidney disease and the sustainable development goals, Bull World Health Organ, 96, 414, 10.2471/BLT.17.206441 Madhi, 2014, Influenza vaccination of pregnant women and protection of their infants, N Engl J Med, 371, 918, 10.1056/NEJMoa1401480 Mameli, 2019, Influenza vaccination: effectiveness, indications, and limits in the pediatric population, Front Pediatr, 7, 317, 10.3389/fped.2019.00317 Mannino, 2012, Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy, Am J Epidemiol, 176, 527, 10.1093/aje/kws313 Marcelli, 2009, Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey, Nephrol Dial Transplant, 24, 3566, 10.1093/ndt/gfp557 Mazagatos, 2018, Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16, PLoS One, 13, 10.1371/journal.pone.0200934 McElhaney, 2005, The unmet need in the elderly: designing new influenza vaccines for older adults, Vaccine, 23, S10, 10.1016/j.vaccine.2005.04.019 Mertz, 2017, Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies, Vaccine., 35, 521, 10.1016/j.vaccine.2016.12.012 Miller, 2012, Immunization in special populations, Adv Pediatr, 59, 95, 10.1016/j.yapd.2012.04.017 Mohan, 2010, Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review, Respirology, 15, 536, 10.1111/j.1440-1843.2010.01722.x Mølgaard-Nielsen, 2019, Effectiveness of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants, J Intern Med, 286, 469, 10.1111/joim.12947 Molinari, 2007, The annual impact of seasonal influenza in the US: measuring disease burden and costs, Vaccine, 25, 5086, 10.1016/j.vaccine.2007.03.046 Montgomery, 2013, Hospital admission due to infections in multiple sclerosis patients, Eur J Neurol, 20, 1153, 10.1111/ene.12130 Mosheni, 2017, Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study, Eur Heart J, 38, 326 Munoz, 2012, Safety of influenza vaccines in pregnant women, Am J Obstet Gynecol, 207, S33, 10.1016/j.ajog.2012.06.072 Murray, 1979, Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women, J Clin Microbiol, 10, 184, 10.1128/JCM.10.2.184-187.1979 Musto, 1997, Vaccination against influenza in multiple myeloma, Br J Haematol, 97, 505 National Advisory Committee on Immunization (NACI), 2019 Nair, 2011, Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis, Lancet, 378, 1917, 10.1016/S0140-6736(11)61051-9 Neidich, 2017, Increased risk of influenza among vaccinated adults who are obese, Int J Obes (Lond), 41, 1324, 10.1038/ijo.2017.131 Newsome, 2019, Outcomes of infants born to women with influenza A(H1N1)pdm09, Birth Defects Res, 111, 88, 10.1002/bdr2.1445 Nicolay, 2019, Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults &65 years of age: meta-analysis of cumulative clinical experience, Int J Infect Dis, 85S, S1, 10.1016/j.ijid.2019.03.026 Ng, 2019, Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis, J Infect Dis, 219, 1525 Nguyen, 2016, Seasonal influenza infections and cardiovascular disease mortality, JAMA Cardiol, 1, 274, 10.1001/jamacardio.2016.0433 Noh, 2016, Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines, Human Vaccin Immunother, 12, 2902, 10.1080/21645515.2016.1191717 Nordin, 2013, Maternal safety of trivalent inactivated influenza vaccine in pregnant women, Obstet Gynecol, 121, 519, 10.1097/AOG.0b013e3182831b83 Nunes, 2015, Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants, J Infect Dis, 212, 1976, 10.1093/infdis/jiv339 Ohfuji, 2013, Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C, Influenza Other Resp Viruses, 7, 456, 10.1111/j.1750-2659.2012.00424.x Ohfuji, 2014, Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients, Liver Int, 34, 700, 10.1111/liv.12295 Ortiz, 2016, A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization, Vaccine, 34, 5400, 10.1016/j.vaccine.2016.07.045 Pasternak, 2012, Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark, BMJ, 344, 10.1136/bmj.e2794 Pebody, 2015, Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15, Euro Surveill, 20, 10.2807/1560-7917.ES.2015.20.39.30029 Pebody, 2018, Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17, Euro Surveill, 23, 10.2807/1560-7917.ES.2018.23.39.1800092 Pepin, 2019, Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: a multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres, Vaccine, 37, 1876, 10.1016/j.vaccine.2018.11.074 Piepoli, 2016, Eur Heart J, 37, 2315, 10.1093/eurheartj/ehw106 Pillsbury, 2015, Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015, Euro Surveill, 20, 10.2807/1560-7917.ES.2015.20.43.30050 Poehling, 2006, The underrecognized burden of influenza in young children, N Engl J Med, 355, 31, 10.1056/NEJMoa054869 Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev Premkumar, 2019, A/H1N1/09 influenza is associated with high mortality in liver cirrhosis, J Clin Exp Hepatol, 9, 162, 10.1016/j.jceh.2018.04.006 Principi, 2015, Influenza vaccination in patients with end-stage renal disease, Expert Opin Drug Saf, 14, 1249, 10.1517/14740338.2015.1053459 Prutsky, 2014, Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review, Pediatr Infect Dis J, 33, e106, 10.1097/INF.0000000000000200 Ramsay, 2019, The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis, BMC Med, 17, 9, 10.1186/s12916-018-1239-8 Rasmussen, 2012, Effects of influenza on pregnant women and infants, Am J Obstet Gynecol, 207, S3, 10.1016/j.ajog.2012.06.068 Regan, 2016, The safety of maternal immunization, Hum Vaccin Immunother, 12, 3132, 10.1080/21645515.2016.1222341 Reichert, 2001, The Japanese experience with vaccinating schoolchildren against influenza, N Engl J Med, 344, 889, 10.1056/NEJM200103223441204 Remschmidt, 2015, Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis, BMC Med, 13 Remschmidt, 2014, Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety, BMC Med, 12, 244, 10.1186/s12916-014-0244-9 Robison, 2018, Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design, Vaccine, 36, 6683, 10.1016/j.vaccine.2018.09.050 Rodrigues, 2020, Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies, Heart, 106, 350, 10.1136/heartjnl-2019-315193 Rubin, 2014, 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host, Clin Infect Dis, 58, 309, 10.1093/cid/cit816 Russell, 2018, Influenza vaccine effectiveness in older adults compared with younger adults over five seasons, Vaccine, 36, 1272, 10.1016/j.vaccine.2018.01.045 Sanei, 2016, Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness, Ther Adv Respir Dis, 10, 349, 10.1177/1753465816646050 Sanyal, 2019, Diminished B-cell response after repeat influenza vaccination, J Infect Dis, 219, 1586, 10.1093/infdis/jiy685 Schütte, 2019, Influenza virus infection as precipitating event of acute-on-chronic liver failure, J Hepatol, 70, 797, 10.1016/j.jhep.2018.11.015 Schwarze, 2018, Influenza burden, prevention, and treatment in asthma—a scoping review by the EAACI influenza in asthma task force, Allergy, 73, 1151, 10.1111/all.13333 Seo, 2015, Long-term immunogenicity and safety of a conventional influenza vaccine in patients with type 2 diabetes, Clin Vaccine Immunol, 22, 1160, 10.1128/CVI.00288-15 Shang, 2018, Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016, Vaccine, 36, 8047, 10.1016/j.vaccine.2018.10.093 Sharpé, 2009, Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial, Am J Kidney Dis, 54, 77, 10.1053/j.ajkd.2008.11.032 Shen, 2013, Seasonal influenza vaccine effectiveness in pre- and full-term children aged 6-23 months over multiple seasons, Vaccine, 31, 2974, 10.1016/j.vaccine.2013.05.011 Sheridan, 2012, Obesity is associated with impaired immune response to influenza vaccination in humans, Int J Obes (Lond), 36, 1072, 10.1038/ijo.2011.208 Simonsen, 1998, Pandemic versus epidemic influenza mortality: a pattern of changing age distribution, J Infect Dis, 178, 53, 10.1086/515616 Small, 2017, The Advisory Committee on Immunization Practices’ controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection, Vaccine, 35, 1110, 10.1016/j.vaccine.2017.01.022 Smetana, 2018, Influenza in the elderly, Hum Vaccin Immunother, 14, 540, 10.1080/21645515.2017.1343226 Smit, 2016, Influenza vaccine is protective against laboratory-confirmed influenza in obese children, Pediatr Infect Dis J, 35, 440, 10.1097/INF.0000000000001029 Song, 2007, Clinical impact of influenza immunization in patients with liver cirrhosis, J Clin Virol, 39, 159, 10.1016/j.jcv.2007.04.018 Su, 2016, Annual influenza vaccination reduces total hospitalization in patients with chronic hepatitis B virus infection: a population-based analysis, Vaccine, 34, 120, 10.1016/j.vaccine.2015.10.129 Sullivan, 2019, Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations, Ther Adv Vaccines Immunother, 7 Sumaya, 1979, Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant, J Infect Dis, 140, 141, 10.1093/infdis/140.2.141 Sung, 2014, Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study, Vaccine, 32, 3843, 10.1016/j.vaccine.2014.04.064 Szucs, 1996, Influenza. The role of burden-off-illness research, Pharmacoeconomics, 16, 27 Tagliabue, 2016, Obesity: impact of infections and response to vaccines, Eur J Clin Microbiol Infect Dis, 35, 325, 10.1007/s10096-015-2558-8 Talbot, 2009, Influenza in older adults: impact of vaccination of school children, Vaccine, 27, 1923, 10.1016/j.vaccine.2009.01.108 Tam, 2018, Immune responses to twice-annual influenza vaccination in older adults in Hong Kong, Clin Infect Dis, 66, 904, 10.1093/cid/cix900 Tamma, 2009, Safety of influenza vaccination during pregnancy, Am J Obstet Gynecol, 201, 547, 10.1016/j.ajog.2009.09.034 Tanzi, 2007, Lack of effect of a booster dose of influenza vaccine in hemodialysis patients, J Med Virol, 79, 1176, 10.1002/jmv.20936 Tapia, 2016, Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial, Lancet Infect Dis, 16, 1026, 10.1016/S1473-3099(16)30054-8 Thompson, 2019, Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016, Clin Infect Dis, 68, 1444, 10.1093/cid/ciy737 Thompson, 2003, Mortality associated with influenza and respiratory syncytial virus in the United States, JAMA, 289, 179, 10.1001/jama.289.2.179 Van Kerkhove, 2011, Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis, PLoS Med, 8, 10.1371/journal.pmed.1001053 Vardeny, 2009, Decreased immune responses to influenza vaccination in patients with heart failure, J Card Fail, 15, 368, 10.1016/j.cardfail.2008.11.009 Vardeny, 2016, Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial, JACC Heart Fail, 4, 152, 10.1016/j.jchf.2015.10.012 Vasileiou, 2017, Effectiveness of influenza vaccines in asthma: a systematic review and meta-analysis, Clin Infect Dis, 65, 1388, 10.1093/cid/cix524 Versluis, 1985, Influenza vaccination in dialysis and transplant patients, Antiviral Res, Suppl 1, 289, 10.1016/S0166-3542(85)80040-1 Vinograd, 2013, Clinical effectiveness of seasonal influenza vaccine among adult cancer patients, Cancer, 119, 4028, 10.1002/cncr.28351 Vojtek, 2018, Maternal immunization: where are we now and how to move forward?, Ann Med, 50, 193, 10.1080/07853890.2017.1421320 Vu, 2002, A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community, Vaccine, 20, 1831, 10.1016/S0264-410X(02)00041-5 Wang, 2016, Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in US Children 6-35 months of age during 2013-2014: results from a phase II randomized trial, J Pediatric Infect Dis Soc, 5, 170, 10.1093/jpids/piv041 Watcharananan, 2014, Comparison of the immunogenicity of a monovalent influenza A/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations, Transplant Proc, 46, 328, 10.1016/j.transproceed.2013.11.063 WHO, 2012, Vaccines against influenza WHO position paper—November 2012, Wkly Epidemiol Rec, 47, 461 WHO, 2017 WHO, 2017 WHO, 2018 WHO, 2018 Wilking, 2010, Mortality of 2009 pandemic influenza A(H1N1) in Germany, Euro Surveill, 15, 10.2807/ese.15.49.19741-en Wilkinson, 2017, Efficacy and safety of high-dose influenza vaccine in elderly adults: a systematic review and meta-analysis, Vaccine, 35, 2775, 10.1016/j.vaccine.2017.03.092 Wongsurakiat, 2004, Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study, Respirology, 9, 550, 10.1111/j.1440-1843.2004.00616.x Yokouchi, 2014, Protective effects of influenza A (H1N1) pandemic 2009 vaccination against the onset of influenza-like illness and asthma exacerbation in Japanese children, J Asthma, 51, 825, 10.3109/02770903.2014.915567 Young, 2019, Semiannual versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator-controlled, randomized superiority trial, Clin Infect Dis, 69, 121, 10.1093/cid/ciy836 Zaman, 2008, Effectiveness of maternal influenza immunization in mothers and infants, N Engl J Med, 359, 1555, 10.1056/NEJMoa0708630 Zbinden, 2014, Influenza vaccination in immunocompromised patients: efficacy and safety, Immunotherapy, 6, 131, 10.2217/imt.13.171 Zhou, 2012, Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008, Clin Infect Dis, 54, 1427, 10.1093/cid/cis211 Zost, 2017, Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains, Proc Natl Acad Sci U S A, 114, 12578, 10.1073/pnas.1712377114